PKM and psoriasis: Recent studies have also found that inhibitors of glucose transporter 1 (Glut1), pyruvate kinase M2 (PKM2), and 2-deoxy-D-glucose (2DG) can alleviate the severity of psoriasis-like skin inflammation (43–45).